Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: Role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1)

被引:45
作者
Castillo, AI [1 ]
Jimenez-Lara, AM [1 ]
Tolon, RM [1 ]
Aranda, A [1 ]
机构
[1] CSIC, Inst Invest Biomed, E-28029 Madrid, Spain
关键词
D O I
10.1210/me.13.7.1141
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PRL gene expression is dependent on the presence of the pituitary-specific transcription factor GHF-1/Pit-1, which is transcribed in a highly restricted manner in cells of the anterior pituitary. In pituitary GH3 cells, vitamin D increases the levels of PRL transcripts and stimulates the PRL promoter. We have analyzed the role of GHF-1 and of the vitamin D receptor (VDR) to confer vitamin D responsiveness to the PRL promoter. For this purpose we have used nonpituitary HeLa cells, which do not express GHF-1. We found that VDR activates the PRL promoter both in a ligand-dependent and -independent manner through a sequence located between positions -45/-27 in the proximal 5'-flanking region. This sequence also confers VDR and vitamin D responsiveness to a heterologous promoter. In the context of the PRL gene, VDR requires the presence of GHF-1 to activate the promoter. Truncation of the last 12 C-terminal amino acids of VDR, which contain the ligand-dependent activation function (AF2), abolishes regulation by vitamin D, suggesting that binding of coactivators to this region mediates ligand-dependent stimulation of the PRL promoter by the receptor. Indeed, expression of the coactivators, steroid hormone receptor coactivator-1 (SRC-1) and CREB-binding protein (CBP), significantly enhances the stimulatory effect of vitamin D mediated by the wild-type VDR but not by the AF2 mutant receptor. Furthermore, CBP also increases the activation of the PRL promoter by GHF-1 and the ligand-independent activation by both wild-type and mutant VDR.
引用
收藏
页码:1141 / 1154
页数:14
相关论文
共 46 条
[1]   CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR [J].
BAKER, AR ;
MCDONNELL, DP ;
HUGHES, M ;
CRISP, TM ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
PIKE, JW ;
SHINE, J ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3294-3298
[2]   The CBP co-activator is a histone acetyltransferase [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 1996, 384 (6610) :641-643
[3]   Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression [J].
Bradford, AP ;
Wasylyk, C ;
Wasylyk, B ;
GutierrezHartmann, A .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (03) :1065-1074
[4]  
BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849
[5]   2 NUCLEAR SIGNALING PATHWAYS FOR VITAMIN-D [J].
CARLBERG, C ;
BENDIK, I ;
WYSS, A ;
MEIER, E ;
STURZENBECKER, LJ ;
GRIPPO, JF ;
HUNZIKER, W .
NATURE, 1993, 361 (6413) :657-660
[6]   MECHANISMS OF NUCLEAR SIGNALING BY VITAMIN-D-3 - INTERPLAY WITH RETINOID AND THYROID-HORMONE SIGNALING [J].
CARLBERG, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 231 (03) :517-527
[7]   Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism [J].
Castillo, AI ;
Tolon, RM ;
Aranda, A .
ONCOGENE, 1998, 16 (15) :1981-1991
[8]   Role of CBP/P300 in nuclear receptor signalling [J].
Chakravarti, D ;
LaMorte, VJ ;
Nelson, MC ;
Nakajima, T ;
Schulman, IG ;
Juguilon, H ;
Montminy, M ;
Evans, RM .
NATURE, 1996, 383 (6595) :99-103
[9]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[10]   LIGAND MODULATES THE CONVERSION OF DNA-BOUND VITAMIN D-3 RECEPTOR (VDR) HOMODIMERS INTO VDR-RETINOID-X RECEPTOR HETERODIMERS [J].
CHESKIS, B ;
FREEDMAN, LP .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :3329-3338